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SUMMARY 
Primary windpipe tumour is extremely rare. Squamous cell carcinoma is the most common malignant form, especially in smokers. The 
radiological appearance of these neoplasms can be classi ed as intra-luminal, wall-thickening, exophytic form; the majority of the lesions 
are obstructive in nature and then tend to extra-luminal invasion. This tumour is usually diagnosed late on account of delayed speci c 
symptoms: haemoptysis, dyspnoea, coughing, hoarseness, stridor. Surgery, followed by adjuvant radiotherapy, is the treatment of choice; 
primary radiotherapy, in inoperable cases, can represent a curative management option. A case of primary tracheal cancer is described and 
a review of the literature is presented. 
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RIASSUNTO 
Il tumore primitivo della trachea è molto raro e il carcinoma squamocellulare è la forma più frequente, soprattutto nei fumatori. Radiolo-
gicamente si possono distinguere forme a sviluppo intraluminale, parietale, eso tico; nella maggior parte dei casi presentano un accresci-
mento in senso ostruttivo e poi tendono alla estensione extraluminale. Questa neoplasia di solito è diagnosticata in fase avanzata a causa 
della comparsa tardiva di sintomi speci ci quali emottisi, dispnea, tosse, raucedine, stridore. La chirurgia e la radioterapia postoperatoria 
rappresentano il trattamento di scelta, nei casi inoperabili la radioterapia da sola può essere una valida opzione terapeutica. Viene pre-
sentato un caso di carcinoma primitivo della trachea e revisionata la letteratura sull’argomento. 
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Introduction
Primary carcinoma of the trachea is not common 1-3.
This rarity makes research into the natural history and 
treatment  very  dif cult 4.  Furthermore,  data  related  to 
these tumours are limited 5. These tumours although ex-
tremely rare present extremely variable clinical and his-
tological features 6.
Most primary cervical tracheal tumours are malignant: ad-
enoid cystic carcinoma (ACC), squamous cell carcinoma 
(SCC), adenocarcinoma 5-12, mucoepidermoid carcinoma, 
carcinoid tumour 3, oat cell carcinoma 13.
SCC is the most common pathology in smokers, ACC is 
more prevalent among non-smokers 5.
Benign tumours are xanthogranuloma and pleomorphic 
adenoma 3. 
A carcinoma arising in the thyroid or oesophagus can 
spread to the trachea; moreover, the trachea can be the 
site of a metastasis from recurrent carcinoid tumour in the 
left main bronchus 9, larynx, lung 1 7, colon 2.
The radiological appearance of the tumours can be classi-
 ed as: intra-luminal, wall-thickening, exophytic form 7.
Endoscopic evaluation reveals that the majority of the le-
sions are bulky and obstructive in nature 6.
Malignant tumours tend to spread to extra-luminal inva-
sion, for example, into the thyroid gland 7.
These tumours also tend to be diagnosed late on account 
of delayed speci c symptoms 2: haemoptysis, dyspnoea, 
cough, hoarseness, stridor being the most common  1 5-7; 
when patients do not present blood in the sputum, the ini-
tial diagnosis is thought to be bronchial asthma; in many 
cases, therefore, suffocation almost occurs before surgical 
treatment 14.
Computed  tomography  (CT),  in  coronal  projection,  is 
the most useful radiological examination for tracheal tu-
mours. Bronchoscopy and radiological examination are G. Abbate et al.
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complementary procedures. The main advantage of imag-
ing is the demonstration of tracheal wall thickening and 
extra-luminal changes 7.
Persistent or progressive local disease can cause compli-
cations:  fatal  haemorrhage,  oesophago-tracheal   stula, 
tracheal necrosis 15, tracheal stenosis 8.
Management of tracheal tumours includes interventional 
endoscopy,  surgery,  radiotherapy,  endoluminal  brachy-
therapy 3.
Extensive segmental resection of the trachea is the treat-
ment of choice for primary malignant, and, occasionally, 
for benign tracheal tumours. Interventional endoscopy is 
part of modern tracheal surgery 3. The resulting tracheal 
clearance has both palliative and curative purposes 3.
Post-operative complications are mediastinitis, bilateral 
pneumonia, wound-healing disorders 3 15.
Radiation therapy is effective treatment for primary tra-
cheal neoplasm. Surgery, followed by adjuvant radiother-
apy and primary radiotherapy in inoperable cases repre-
sent potentially curative treatment options 5 9 15.
Positive lymph nodes or invasive disease at resection mar-
gins appear to have an adverse effect on the management 
of SCC; such an effect is not demonstrable with adenoid 
cystic carcinoma 16.
Surgery is the treatment of choice and up to 50% of the 
trachea can be resected with modern techniques 4 8.
With tracheostomy a curative excision or a palliative exci-
sion is possible 18.
The sleeve trachea resection is one of the optimal sur-
gical modalities, the other options are: partial tracheal 
wall resection, immediate tracheal reconstruction, total 
laryngectomy + partial resection of trachea and thyroid 
lobectomy  8  12,  resection  and  primary  reconstruction, 
laryngotracheal resection, cervico-mediastinal exentera-
tion, carinal resection and reconstruction 16.
Trachea  anastomosis  is  suitable  for  small  defects.  The 
platysma myocutaneous  ap combined with the facial  ap 
of the sternohyoid muscle, sternocleidomastoid myoperio-
steal  ap and the pectoralis major musculocutaneous  ap 
are applied to reconstruct the defects of cervical trachea 11.
Resection  and  post-operative  radiation  therapy  are  the 
treatment of choice, complete resection is the desired goal 
and demands knowledge of the principles of tracheal sur-
gery 10.
Debulking surgery, followed by radiotherapy, may pro-
vide effective and permanent control in ACC6 and can be 
effective in obviating local recurrence 14.
Endo-bronchial high dose-rate brachytherapy may be used 
for tracheal tumours, even as a boost for external beam ir-
radiation or in recurrences. Long-term survival may also 
be expected, particularly for tumours with adenoid cystic 
histology 17.
Palliation has improved with the introduction of laser re-
section, brachytherapy and stents. SCC may have a better 
prognosis, in the trachea, than in the lung 4.
According to some Authors, patients who undergo pri-
mary surgery with adjuvant radiotherapy appear to have 
better disease-speci c and overall survival rates compared 
with  patients  undergoing  primary  radiotherapy  with  or 
without chemotherapy 5.
After surgical management, the 3- and 5-year surviv-
al rates are 79.80%, 48.36% for ACC, 80% and 20% 
for SCC 8; in 1, 3, 5, 10 years are 82.3%, 75%, 75%, 
50% 18.
Carvalho Hde, et al. presented their experience with high 
dose-rate endobronchial brachytherapy; they reported a 
good local control, at the time of the  rst bronchoscopic 
control. They treated 4 patients with non-resectable tra-
cheal tumour: two patients with SCC died at the 6th and 
33rd month, respectively, after treatment, only the second 
presented local recurrence. The other two patients were 
alive after 64 and 110 months of follow-up17.
Some Authors  discussed  the  role  of  radiation  therapy 
alone: the median survival for SCC was 33 months, for 
ACC 94.2. The 1-, 3-, 5-year survival rates were 64.7%, 
64.7%, 26% for SCC, 85.7%, 85.7%, 85.7% for ACC. Pa-
tients with ACC and patients with complete remission fol-
lowing treatment had a signi cantly better survival prob-
ability 15.
Other Authors reported that of 14 resected patients suf-
fering from primary tracheal tumours, at the last follow 
up (10 years), 9 are still alive. These Authors observed 5 
long-term survivors > 6 years with adenoid cystic carci-
noma or muco-epidermoid carcinoma. 
The 5-year survival rate for low grade malignant tumours 
arising in the trachea (carcinoid, muco-epidermoid carci-
noma, adenoid cystic carcinoma) is 78.8% 3.
Case report
R.V. a 54-year-old male, heavy drinker and smoker, had 
been suffering from dyspnoea, sometimes haemoptysis, 
cough, weight loss ~10 Kg for approximately 2 months.
The thorax studied by standard radiology showed a left 
pneumonia,  routine  blood  tests  revealed  leukocytosis, 
neutrophilia, high levels of transaminases. Nevertheless, 
the patient refused admission to hospital and, therefore, 
underwent  treatment  with  ceftriaxone,  moxi oxacina, 
acetylcysteine, prednisone at home.
After 9 days, X-rays and blood tests had improved.
After 15 days dyspnoea had become more severe and was 
treated as asthma with beclomethasone aerosol and oral 
prednisone.
The rhino-pharyngo-laryngeal region, explored by  ex-
ible  beroptic examination, showed evidence of right la-
ryngeal palsy.
Radiographic examination of the oesophagus was normal 
(Fig. 1).
A tracheobronchoscopic examination demonstrated evi-
dence of a voluminous tracheal mass; during performance Primary squamous cell carcinoma of the trachea
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of this test, heart arrest with respiratory failure occurred 
and the patient was reanimated with heart massage and 
mechanical respiration.
Three hours later the patient underwent tracheostomy (IV 
– V tracheal ring).
CT showed a voluminous wall-thickening solid tracheal 
mass, extending from the subglottic space to the upper 
mediastinic space, about 6-7 cm in length (Figs. 2, 3, 4).
Due to the size of the lesion, the patient was submitted 
to palliative radiotherapy on T and N (trachea and neck), 
total dose 50.4 Gy, fractionated 1.8 Gy/die, with boosts on 
the trachea reaching 61.2 Gy. During follow-up, a relapse 
was observed on the posterolateral wall of the trachea, 
about 4 months after radiotherapy.
R.V. died one year after diagnosis.
Discussion and conclusions
Primary cancer of the trachea is extremely rare and, there-
fore, pertinent data are limited. 
Most primary cervical tracheal tumours are malignant, for 
example, SCC in smokers, ACC in non-smokers, carcinoid 
tumour, mucoepidermoid carcinoma, oat cell carcinoma; 
benign neoplasms can also be observed, for example, xan-
thogranuloma and pleomorphic adenoma. 
We  can  diagnose  tumours  localized  in  the  trachea  as 
metastasis  from  tumours  of  thyroid  gland,  bronchus, 
oesophagus, larynx, lung, colon.
Tracheal neoplasms, benign and malignant, are usually 
bulky and obstructive; they increase in size and tend even-
tually to extra-luminal invasion into the thyroid or upper 
mediastinic space. 
Unfortunately,  these  neoplasms  are  often  diagnosed 
late on account of delayed speci c symptoms (blood 
sputum, coughing, dyspnoea). Very often, the patient 
undergoes treatment for bronchial asthma, this mistake 
thus delays diagnosis and the tracheal tumour becomes 
inoperable.
Tracheo-bronchoscopy and CT, in coronal projection, are 
basic examinations for these problems.
Surgery (segmental resection, sleeve resection, immediate 
or secondary reconstruction using  aps) followed by ra-
diotherapy is the treatment of choice. Radiotherapy alone 
is a possible treatment option in inoperable cases.
Endo-bronchial brachytherapy may be used for tracheal 
tumours, especially if the tumour is small in size.
Palliation has improved with the introduction of laser re-
section and stents.
Fig. 1. Barium swallow – oesophagus appears normal.
Fig. 2. CT scan shows a volumi-
nous wall-thickening solid tracheal 
mass.
Fig. 3. CT scan shows postero-
lateral  tracheal  wall  inﬁltration  in 
mediastinum.
Fig. 4. Sagittal CT shows trache-
al tube in its usual site with tumour 
surrounding it.G. Abbate et al.
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The Authors chose to publish this report, given the rare 
occurrence of this form of cancer.
A smoker presenting dyspnoea could be carrier of a tra-
cheal neoplasm and early diagnosis is very important for 
the management.
We pay particular attention in all cases of dyspnoea, especially 
if antibiotics and steroids have not led to an improvement in 
symptoms. A rhino-pharyngo-laryngeal examination is always 
necessary, a CT of the thorax, in a coronal projection, can clar-
ify diagnosis, thus making correct management possible.
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